Firefly Neuroscience (NASDAQ:AIFF) Trading Down 3.9% – What’s Next?

Firefly Neuroscience, Inc. (NASDAQ:AIFF) shares fell 3.9% during mid-day trading on Tuesday . The company traded as low as $3.43 and last traded at $3.70. 523,068 shares were traded during mid-day trading, a decline of 96% from the average session volume of 11,935,686 shares. The stock had previously closed at $3.85.

Firefly Neuroscience Trading Down 3.9 %

The company’s fifty day moving average price is $2.92.

Hedge Funds Weigh In On Firefly Neuroscience

An institutional investor recently bought a new position in Firefly Neuroscience stock. Waldron Private Wealth LLC bought a new position in Firefly Neuroscience, Inc. (NASDAQ:AIFF) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 12,000 shares of the company’s stock, valued at approximately $36,000. Waldron Private Wealth LLC owned 1.79% of Firefly Neuroscience as of its most recent SEC filing. Hedge funds and other institutional investors own 4.96% of the company’s stock.

About Firefly Neuroscience

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.